Sino Biopharmaceutical Limited (OTCMKTS:SBMFF – Get Free Report)’s stock price hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $0.31 and last traded at $0.31, with a volume of 0 shares trading hands. The stock had previously closed at $0.31.
Sino Biopharmaceutical Stock Performance
The company has a 50-day moving average of $0.33 and a 200-day moving average of $0.36.
About Sino Biopharmaceutical
Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company offers oncology medicines, including anlotinib hydrochloride capsules under Focus V brand, penpulimab injection under Annike brand, efbemalenograstin alfa injection under Yilishu brand, pomalidomide capsules under Anyue brand, bevacizumab injection under Anbeisi brand, rituximab injection under Delituo brand, and trastuzumab for injection under Saituo brand; liver disease medications, such as magnesium isoglycyrrhizinate injection under Tianqing Ganmei brand and entecavir dispersible tablets under Runzhong brand; and respiratory system medicines comprising budesonide suspension for inhalation under Tianqing suchang brand and colistimethate sodium for injection under Tianyun brand.
See Also
- Five stocks we like better than Sino Biopharmaceutical
- What is a Bond Market Holiday? How to Invest and Trade
- Celebrate July 4th with These Red, White, & Blue Chip Stocks
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- AbbVie Stock: A Perfect Dip for Investors to Buy
- Dividend Capture Strategy: What You Need to Know
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
Receive News & Ratings for Sino Biopharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sino Biopharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.